VANECK PHARMACEUTICAL ETF - USD |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.1 EUR | -0.18% |
|
+0.95% | +13.76% |
Investment objective
VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 770.3 USD | -0.11% | +1.53% | +32.38% | 9.76% | ||
| 154.3 USD | +0.03% | +2.96% | -1.52% | 6.36% | ||
| 130.9 USD | +0.03% | +0.69% | +20.12% | 5.84% | ||
| 165.9 USD | +0.96% | +3.38% | +7.23% | 5.46% | ||
| 222.1 USD | +0.13% | -1.16% | +8.09% | 4.82% | ||
| 562.8 USD | +1.27% | +0.53% | +21.57% | 4.48% | ||
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 83.1 | -0.18% |
| 24-05-16 | 83.25 | +0.11% |
| 24-05-15 | 83.16 | +0.33% |
| 24-05-14 | 82.89 | 0.00% |
| 24-05-13 | 82.89 | +0.08% |
Other stock markets
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 01:47 pm EDT
More quotesETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2011-12-18
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 500 M€ |
|---|---|
| AuM 1M | 510 M€ |
| AuM 3 months | 409 M€ |
| AuM 6 months | 362 M€ |
| AuM 12 months | 364 M€ |
- Stock Market
- ETF
- VEFV ETF
